Skip to content
‹ Back to IndustriesHealthcare

It’ll Take a Village to Deliver the Innovative, Less Invasive, Affordable Solutions to the Healthcare Market with Raja Abid

There’s no getting around the fact that the healthcare industry needs solutions to help solve its myriad challenges. A holistic approach to healthcare solutions is a pathway Raja Abid, Healthcare Economic Leader at Boston Scientific, believes can deliver innovative, less invasive, and affordable solutions to the healthcare market. Abid kicked off his career in med…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Start free

There’s no getting around the fact that the healthcare industry needs solutions to help solve its myriad challenges. A holistic approach to healthcare solutions is a pathway Raja Abid, Healthcare Economic Leader at Boston Scientific, believes can deliver innovative, less invasive, and affordable solutions to the healthcare market.

Abid kicked off his career in med school. He discovered there were so many facets to healthcare he wanted to learn different sides of the market. Abid got his MBA in healthcare administration, which opened his eyes to the many possibilities for him to make a difference. Keeping an open mind is a trait Abid values, and it’s what guided him through his career and led him to Boston Scientific.

All areas within healthcare offer tremendous value and opportunities to create solutions, but the siloing that often accompanies these areas must dissipate to allow for better communication. “The only way you’re going to improve quality, value, and delivery of care, is when everybody starts talking to each other, builds care pathways that make sense, efficient, and highly effective,” Abid said. Still, Abid believes the next ten years in healthcare will focus on solving this challenge.

In Abid’s role with Boston Scientific, he provides economic support data, so healthcare organizations understand the financial impact of the devices they purchase. A device may seem like a significant spend, but long-term financial benefits and positive patient results generated from that device could be tremendous.

Seeing healthcare from the side of a device manufacturer, Abid knows that solutions come from partnerships. “Medical device companies come up with new products and technologies. We educate the physicians and the patients on their options because, as you can imagine, most patients go to a physician, and a physician’s going to do what they’ve been doing for the last fifteen to twenty years.” Educating the healthcare community on the latest innovations can make all the difference.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512